BioIVT Launches Visionaire™ to Enhance Drug Development Workflows and Drive Actionable Insights for Precision Medicine
AI-powered drug discovery and precision medicine demands more than just data—they require high-quality, reproducible insights. That’s where Visionaire™ by BioIVT comes in.
Backed by 30+ years of BioIVT’s expertise in collecting and curating biospecimens, Visionaire™ offers:
-
Clinically Curated Biospecimens: Access real-world data collected to clinical and regulatory standards.
-
Rich Data Insights: Combine biospecimens with deep clinical, imaging, and biomarkers data.
-
Immediate Availability: Streamline your research process with AI-ready data for oncology, neurology, and beyond.
Whether you're identifying biomarkers for companion diagnostics, developing digital pathology models, or accelerating drug discovery, Visionaire™ bridges the gap between potential and progress.